ArticleMethods in molecular biology (Clifton, N.J.)2026

Phase 1/2a Clinical Trial Protocol for Lentiviral Vector-Based Retinal Gene Therapy to Slow the Progression of Retinitis Pigmentosa.

Takahiro Hisai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.